Candela, a Syneron company, has received SFDA (State Food and Drug Administration) of China approval for the Alex TriVantage multi-wavelength, Q-switched laser system and the GentleMax multiple wavelength workstation sale throughout the People's Republic of China, including Hong Kong.
Candela said that receipt of the SFDA certificates will allow it to begin the sales process and launch official marketing programs for these products, creating a host of new market opportunities.
The Q-switched Laser-Pumped-Laser (LPL) technology of the Alex TriVantage laser provides 755nm, 532nm and 1064nm output wavelengths, making Alex TriVantage versatile. The addition of a long-pulse mode at 755nm offers advanced treatments for a wider variety of pigmented lesions without long-term side effects.
By integrating two of aesthetic laser medicine’s devices, the GentleLASE and GentleYAG, into a configurable, upgradeable workstation, the GentleMax has made treatment for a wider range of patient concerns readily available.
The GentleMax laser system features both 755-nm and 1064-nm wavelengths and may be used to provide permanent hair reduction on all skin types and tanned skin as well as the treatment of vascular and pigmented lesions, wrinkle reduction and skin tightening. With GentleMax, it is possible for one device to do the work of two or more.
Louis Scafuri, chief executive officer of Syneron said: “The Alex TriVantage is our first Q-switched alexandrite laser to be approved in China. With its Laser-Pumped-Laser (LPL) technology and GentleMax’s multiple wavelengths and uses, a greater number of physicians will be able to offer a wider variety of services for conditions with fewer devices. Moreover, this approval enables us to offer a more complete range of highly effective aesthetic solutions in the world’s largest market.”